- 2025-09-26 10:58NSC 31205 6320-51-0
- 2025-09-26 10:58Brepocitinib (PF-06700841) 1883299-62-4
- 2025-09-26 10:58TLR7/8 agonist-5d 1620278-72-9
- 2025-09-26 10:58EGFR kinase inhibitor 2
- 2025-09-26 10:58MNK/PIM-IN-1 2430792-91-7
- 2025-09-26 10:58Upadacitinib 1310726-60-3
- 2025-09-26 10:58TLR7/8 agonist 9 2649170-17-0
- 2025-09-26 10:58EGFR inhibitor 879127-07-8
- 2025-09-26 10:58INCB053914 phosphate 2088852-47-3
- 2025-09-26 10:58TLR7/8 agonist 8 2649170-16-9
- 2025-09-26 10:58EAI045 1942114-09-1
- 2025-09-26 10:58WP1066 857064-38-1
- 2025-09-26 10:58INCB053914 1620012-39-6
- 2025-09-26 10:58TLR7/8 agonist 7 2567953-47-1
- 2025-09-26 10:58DZD1516 2387570-00-3
- 2025-09-26 10:58Tubulin/JAK2-IN-1 2933938-46-4
- 2025-09-26 10:58IBL-302 (AMU302) 1414455-21-2
- 2025-09-26 10:57Dosimertinib-d5 mesylate 2403760-72-3
- 2025-09-26 10:57Tofacitinib-13C3 (Tasocitinib-13C3; CP-690550-13C3)
- 2025-09-26 10:57TLR7/8 agonist 4 2388520-33-8
